SCHEMBL7400655

SCHEMBL7400655

CC1CN(c2ccc(C(N)=O)cc2)CC(C)N1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 1/20 0.47
CHRNA10 Q9GZZ6 1/20 0.47
CHRNA9 Q9UGM1 1/20 0.47
GPR119 Q8TDV5 1/20 0.43
ACVR1 Q04771 1/20 0.42
USP2 O75604 1/20 0.41
FGFR1 P11362 4/20 0.41
NTRK1 P04629 1/20 0.41
RET P07949 1/20 0.41
PDGFRB P09619 1/20 0.41
MARK3 P27448 1/20 0.41
TNK2 Q07912 1/20 0.41
DDR1 Q08345 1/20 0.41
MAP4K2 Q12851 1/20 0.41
MAP3K11 Q16584 1/20 0.41
DDR2 Q16832 1/20 0.41
MARK2 Q7KZI7 1/20 0.41
MAP4K3 Q8IVH8 1/20 0.41
MAP4K1 Q92918 1/20 0.41
AURKB Q96GD4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17530499 1.00 CHRNA7 (0.47) CHRNA7CHRNA10CHRNA9GPR119ACVR1
SCHEMBL19057096 0.86 CHRNA7 (0.42) CHRNA7CHRNA10CHRNA9GPR119ACVR1
SCHEMBL1665710 0.85 USP2 (0.58) USP2FGFR1NTRK1RETPDGFRB
SCHEMBL4435359 0.85 USP2 (0.58) USP2FGFR1NTRK1RETPDGFRB
SCHEMBL24115187 0.85 NPC1 (0.51) GPR119USP2FGFR1NTRK1RET
SCHEMBL8183599 0.83 ACVR1 (0.48) CHRNA7CHRNA10CHRNA9GPR119ACVR1
SCHEMBL64018 0.81 ALDH1A1 (0.57) FGFR1NTRK1RETPDGFRBMARK3
SCHEMBL2771145 0.80 MAPT (0.53) CHRNA7CHRNA10CHRNA9GPR119ACVR1
SCHEMBL25629582 0.79 CHRNA7 (0.47) CHRNA7CHRNA10CHRNA9GPR119ACVR1
Hydrochloric Acid SCHEMBL16210291 0.79 MAPT (0.51) CHRNA7CHRNA10CHRNA9GPR119ACVR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6133446-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 2000-10-17 US disclosed
EP-0737189-B1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS UPJOHN CO (US) 1999-07-28 EP disclosed
EP-0737189-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1996-10-16 EP disclosed
WO-1995018118-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS THE UPJOHN COMPANY (US) 1995-07-06 WO disclosed